The 14th International Conference on Alzheimer's Drug Discovery, 9 - 10 September 2013, in Jersey City, New Jersey.
The following conference was the 14th International Conference on Alzheimer's Drug Discovery held 9 - 10 September 2013, in Jersey City, NJ. The conference attracted about 140 attendees with 49% from academia, 36% from industry and private practice, 10% from nonprofit organizations and 2% from the government. The meeting had two plenary speakers that kicked off each morning of the conference and then two sessions each day to cover different aspects of Alzheimer's disease drug discovery. There were sessions on neuroprotection, mitochondrial function, biomarkers, ApoE, tau and protein clearance. The conference was organized by the Alzheimer's Drug Discovery Foundation (ADDF) with all of the presenters supported by grants awarded by the ADDF. The conference had financial support from the pharmaceutical companies Merck & Co., Eli Lilly & Co. and Pfizer, Inc. Friends, exhibitors and media partners also helped financially support the conference.
Brigham and Women's Hospital, Harvard Medical School, Department of Neurology , 65 Landsdowne Street, Cambridge, MA 02139 , USA mglicksman@rics.bwh.harvard.edu.
Marcie A
MA
Glicksman
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D000818:Animals; D055808:Drug Discovery; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use
D018696:Neuroprotective Agents